A Study to Examine the Efficacy, Safety and Tolerability, and Pharmacokinetics of Exenatide Once Monthly Suspension

Summary

The purpose of Study BCB111 is to collect efficacy, pharmacokinetic, pharmacodynamic, safety, and tolerability data in patients with type 2 diabetes to assess the feasibility of once monthly dosing of the exenatide suspension formulation.

Timeline

Start

2010-05

Primary completion

2010-12

Completion

2010-12

Publications

• Wysham CH, MacConell L, Hardy E. Efficacy and Safety of Multiple Doses of Exenatide Once-Monthly Suspension in Patients With Type 2 Diabetes: A Phase II Randomized Clinical Trial. Diabetes Care. 2016 Oct;39(10):1768-76. doi: 10.2337/dc16-0238. Epub 2016 Jul 19.

Drugs

Indications